Maintenance therapy in non-small cell lung cancer

被引：21

作者：

Genestreti, Giovenzio ^{[1
]}

Di Battista, Monica ^{[1
]}

Cavallo, Giovanna ^{[1
]}

Bartolotti, Marco ^{[1
]}

Brandes, Alba A. ^{[1
]}

机构：

[1] IRCCS, Dept Med Oncol, Azienda USL, Inst Neurol Sci, Bologna, Italy

来源：

EXPERT REVIEW OF ANTICANCER THERAPY | 2015年 / 15卷 / 07期

关键词：

advanced non-small cell lung cancer; lung cancer; maintenance therapy; Phase III randomized trial; review; QUALITY-OF-LIFE; PHASE-III TRIAL; PLATINUM-BASED CHEMOTHERAPY; CLINICAL-PRACTICE GUIDELINES; PEMETREXED PLUS CISPLATIN; NORTON-SIMON HYPOTHESIS; DOUBLE-BLIND; COST-EFFECTIVENESS; STAGE-IIIB; RANDOMIZED-TRIAL;

D O I：

10.1586/14737140.2015.1052410

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Several randomized trials have investigated the role of maintenance treatment for patients with advanced non-small cell lung cancer (NSCLC) not progressed after completion of first-line chemotherapy, with good performance score (PS) and no persistent chemotherapy-induced toxicity. Two separate strategies have been developed: the immediate use of non-cross-resistant drug (switch maintenance or early second-line therapy) or the continuation of platinum partner alone (continuation maintenance) or in combination with other drug (combination maintenance). Here we discuss how the benefits demonstrated in these studies may change clinical practice (in terms of potential toxicity and costs) and reflect on factors that may identify subgroups of patients who might benefit from maintenance therapy in general, and which maintenance therapy specifically.

引用

页码：839 / 846

页数：8

共 45 条

[1] Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Versus Placebo as Maintenance Therapy for Advanced Nonsmall-cell Lung Cancer: A Meta-analysis of Randomized Controlled Trials [J].

Alimujiang, S. ;

Zhang, Tao ;

Han, Zhi-Gang ;

Yuan, Shuai-Fei ;

Wang, Qiang ;

Yu, Ting-Ting ;

Shan, Li .

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2013, 14 (04) :2413-2419

[2]

[Anonymous], 2012, NCCN Clinical Practice Guidelines in Oncology: Breast Cancer

[3] 2011 Focused Update of 2009 American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non-Small-Cell Lung Cancer [J].

Azzoli, Christopher G. ;

Temin, Sarah ;

Aliff, Timothy ;

Baker, Sherman, Jr. ;

Brahmer, Julie ;

Johnson, David H. ;

Laskin, Janessa L. ;

Masters, Gregory ;

Milton, Daniel ;

Nordquist, Luke ;

Pao, William ;

Pfister, David G. ;

Piantadosi, Steven ;

Schiller, Joan H. ;

Smith, Reily ;

Smith, Thomas J. ;

Strawn, John R. ;

Trent, David ;

Giaccone, Giuseppe .

JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (28) :3825-3831

[4]

Barata FJ, 2007, J THORAC ONCOL S, V2

[5] Randomized Phase III Trial of Maintenance Bevacizumab With or Without Pemetrexed After First-Line Induction With Bevacizumab, Cisplatin, and Pemetrexed in Advanced Nonsquamous Non-Small-Cell Lung Cancer: AVAPERL (MO22089) [J].

Barlesi, Fabrice ;

Scherpereel, Arnaud ;

Rittmeyer, Achim ;

Pazzola, Antonio ;

Tur, Neus Ferrer ;

Kim, Joo-Hang ;

Ahn, Myung-Ju ;

Aerts, Joachim G. J. V. ;

Gorbunova, Vera ;

Vikstrom, Anders ;

Wong, Elaine K. ;

Perez-Moreno, Pablo ;

Mitchell, Lada ;

Groen, Harry J. M. .

JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (24) :3004-+

[6] Single agent maintenance therapy for advanced stage non-small cell lung cancer: A meta-analysis [J].

Behera, Madhusmita ;

Owonikoko, Taofeek K. ;

Chen, Zhengjia ;

Kono, Scott A. ;

Khuri, Fadlo R. ;

Belani, Chandra P. ;

Ramalingam, Suresh S. .

LUNG CANCER, 2012, 77 (02) :331-338

[7] Multicenter, randomized trial for stage IIIB or IV non-small-cell lung cancer using weekly paclitaxel and carboplatin followed by maintenance weekly paclitaxel or observation [J].

Belani, CP ;

Barstis, J ;

Perry, MC ;

La Rocca, RV ;

Nattam, SR ;

Rinaldi, D ;

Clark, R ;

Mills, GM .

JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (15) :2933-2939

[8]

Belani CP, 2010, PR ASCO J CLIN ONCOL, V28

[9] Cisplatin and gemcitabine first-line chemotherapy followed by maintenance gemcitabine or best supportive care in advanced non-small cell lung cancer: A phase III trial [J].

Brodowicz, T ;

Krzakowski, M ;

Zwitter, M ;

Tzekova, V ;

Ramlau, R ;

Ghilezan, N ;

Ciuleanuf, T ;

Cucevic, B ;

Gyurkovits, K ;

Ulsperger, E ;

Jassem, J ;

Grgic, M ;

Pinar, S ;

Szilasi, M ;

Wiltschke, C ;

Wagnerova, M ;

Oskina, N ;

Soldatenkova, V ;

Zielinski, C ;

Wenczl, M .

LUNG CANCER, 2006, 52 (02) :155-163

[10] Erlotinib as maintenance treatment in advanced non-small-cell lung cancer: a multicentre, randomised, placebo-controlled phase 3 study [J].

Cappuzzo, Federico ;

Ciuleanu, Tudor ;

Stelmakh, Lilia ;

Cicenas, Saulius ;

Szczesna, Aleksandra ;

Juhasz, Erzsebet ;

Esteban, Emilio ;

Molinier, Olivier ;

Brugger, Wolfram ;

Melezinek, Ivan ;

Klingelschmitt, Gaelle ;

Klughammer, Barbara ;

Giaccone, Giuseppe .

LANCET ONCOLOGY, 2010, 11 (06) :521-529

← 1 2 3 4 5 →